AOMR

In the past six months, AOMR reported its Q4 2025 earnings with total interest income exceeding estimates but distributable earnings slightly below, and shares declined slightly. The company declared two quarterly common stock dividends of $0.32 per share. AOMR reported a GAAP net loss for Q1 2026, attributed to net realized and unrealized losses on loans, securitization-related debt, and derivatives, influenced by macroeconomic market volatility and geopolitical events. Jones Trading maintained a "Buy" rating with a $10.50 price target, while UBS maintained a "Neutral" rating but lowered its price target to $9.75. Some analysts upgraded AOMR from "Hold" to "Buy," supported by non-QM loan demand and portfolio growth. AOMR stock was up 10.24% in the 30 days leading up to May 5, 2026.